Heart valve disease presenting in adults: investigation and management

Supporting evidence

• Economic analysis

• MitraClip Economic analysis (PDF 1.36 MB)

  Published:

  24 November 2021

• TAVI Economic analysis (PDF 1.32 MB)

  Published:

  24 November 2021

• Evidence review

• Evidence reviews – November 2021

• A: Symptoms and signs indicating need for echocardiography or direct referral to a specialist (PDF 2.46 MB)

  Published:

  17 November 2021

• B: Indications for referral to a specialist following echocardiography (PDF 1.41 MB)

  Published:

  17 November 2021

• C: Pharmacological management (PDF 2.33 MB)

  Published:

  17 November 2021

• D: Indications for intervention (PDF 2.16 MB)

  Published:

  17 November 2021

• E: Stress testing and stress echocardiography in determining need for intervention (PDF 1.83 MB)

  Published:

  17 November 2021

• F: CT and MRI indications for intervention (PDF 2.31 MB)

  Published:

  17 November 2021

• G: Monitoring of people with heart valve disease and no current indication for intervention (PDF 726 KB)

  Published:

  17 November 2021

• H: Transcatheter intervention, surgery or conservative management in heart valve disease (PDF 4.43 MB)

  Published:

  17 November 2021

• I: Repeat intervention for failure of biological or repaired valves (PDF 1.03 MB)

  Published:

  17 November 2021

• J: Anticoagulant and/or antiplatelet therapy for biological prosthetic valves and after valve repair (PDF 1.38 MB)

  Published:

  17 November 2021

• K: Monitoring in people with repaired or replaced heart valves (PDF 535 KB)

  Published:

  17 November 2021

• L: Information and advice (PDF 1.21 MB)

  Published:

  17 November 2021